Da Vinci Systems Market Size and Trends

The Da Vinci systems market size is expected to reach US$ 5.30 billion by 2030, from US$ 1.76 billion in 2023, at a CAGR of 17.1% during the forecast period. Da Vinci surgical systems are robotic technologies that assist surgeons in performing minimally invasive surgeries. These systems provide surgeons with improved precision, flexibility, and control during complex procedures. The advantages of Da Vinci surgery include smaller incisions, reduced blood loss, quicker recovery times, and fewer complications. The key drivers of this market include the increasing adoption of minimally invasive surgeries, technological advancements in robotic surgery, and a rising prevalence of chronic diseases. For instance, in October 2022, Medtronic plc, a global healthcare technology leader, announced three significant global market-entrance and indication expansion approvals for its Hugo robotic-assisted surgery (RAS) system. The new system approvals and indications set the stage for significant access across Europe, North America, and Asia, extending the benefits of minimally invasive surgery to new global audiences.

The Da Vinci systems market is segmented by product type, by application, by end user, and by region. By product type, the instruments & accessories segment accounted for the largest market share in 2022. This is due to the recurrent purchase of instruments & accessories compared to robotic systems and the demand for advanced instruments.

Da Vinci Systems Market Drivers:

Increasing adoption of minimally invasive surgeries: The growing adoption of minimally invasive surgeries such as laparoscopy is a major factor driving the Da Vinci systems market growth. Compared to traditional open surgeries, minimally invasive procedures result in shorter hospital stays, lower readmission rates, and reduced pain. Robotic surgery with the Da Vinci system further enhances the benefits of minimally invasive surgery through improved dexterity, precision, and control. The system provides surgeons with 3D-HD visualization, intuitive instrument movement, and superior ergonomics. This has led to its increased adoption for complex minimally invasive procedures across gynecology, urology, general surgery, cardiothoracic, and head and neck specialties. For instance, according to data published by the National Center for Biotechnology Information (NCBI) in September 2022, in 2016, 2017, and 2018, there were a total of 10.6 million, 10.6 million, and 10.7 million surgical procedures performed, respectively. Out of these, about 17% of the procedures in 2016, 17.4% in 2017, and 18% in 2018 were minimally invasive surgeries.
Technological advancements in surgical robotics: Continuous advancements in surgical robotics technology such as instrument articulation, motion scaling, and tremor elimination allow for more precise and safer procedures. Intuitive Surgical, the pioneer in robotic surgery, continues to launch new and advanced Da Vinci systems with improved capabilities. For instance, the latest Da Vinci X and Xi systems include thinner arms, longer instrument shafts, and imaging enhancement features compared to their predecessors. The company also launched Da Vinci SP, the first robotic-assisted surgical system optimized for single port procedures. Such technological improvements are fueling the adoption of robotic surgery, thereby driving market growth. For instance, in June 2023, Apollo Hospitals, a pioneer in healthcare innovation, launched the Da Vinci Xi Robotic Surgical System, a groundbreaking advancement in surgical procedures that promises enhanced precision and superior patient care. Cutting-edge technology represents a significant achievement that has the potential to transform surgical healthcare, creating new opportunities for both patients and surgeons.
Improved clinical outcomes: Numerous clinical studies have demonstrated the clinical benefits of Da Vinci surgery over open and laparoscopic approaches. Robotic surgery has been associated with lower rates of complications, shorter hospital stays, less blood loss, and quicker recovery in procedures such as prostatectomy, hysterectomy, mitral valve repair, and lung resection. Growing evidence of favorable surgical outcomes is encouraging patients and surgeons to opt for robot-assisted procedures using the Da Vinci system. This is expected to propel market growth during the forecast period.
Rising prevalence of chronic diseases and cancers: The increasing prevalence of chronic conditions such as cardiovascular disease, hernia, gynecological disorders, and cancers requiring surgical treatment is driving the demand for minimally invasive surgical procedures using the Da Vinci system. With its wristed instruments and HD 3D visualization, the system allows complex cancer and reconstructive surgeries to be performed with enhanced precision and control. The rising volume of surgical procedures is therefore expected to support market growth going forward. As per the data provided by World Health Organization on September 16, 2023, chronic diseases are responsible for 41 million deaths annually, which is approximately 74% of all global fatalities. Each year, 17 million people succumb to NCDs before reaching the age of 70, with 86% of these premature deaths occurring in low- and middle-income nations. The majority of NCD-related deaths, accounting for 77%, are concentrated in low- and middle-income countries. The leading causes of NCD deaths include cardiovascular diseases, claiming the lives of 17.9 million individuals each year, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including deaths due to kidney disease caused by diabetes).

Da Vinci Systems Market Opportunities:

Emerging markets represent significant growth opportunities: Emerging markets such as China, India, Brazil, and Mexico have significant growth potential for Da Vinci surgical systems owing to their underpenetrated nature, rapidly improving healthcare infrastructure, and rising medical tourism. As awareness regarding the benefits of minimally invasive surgery increases in these regions, major players can focus on increasing their footprint by engaging in partnerships, training programs, and regulatory approvals. For instance, intuitive surgical is expanding training centers and distribution partnerships in India to expand robotic surgery adoption. Capturing these high-growth markets will open up substantial opportunities.
Development of low-cost robotic surgery systems: While Da Vinci leads the surgical robotics space, the development of lower-cost robotic surgery systems presents a major opportunity for new market entrants. Startups such as CMR Surgical, Medtronic, and Johnson & Johnson are working on next-gen, flexible, portable robotic surgery systems for under US$500,000 to improve access to robotic surgery. With pressures to reduce healthcare costs globally, affordable surgical robots could witness high demand from hospitals and ASCs, thereby driving market growth.
Growing applications in new procedures: The capabilities of Da Vinci and next-gen robotic systems are being explored for an expanding range of surgical procedures beyond urology and gynecology such as cardiothoracic, head and neck, colorectal, and reconstructive surgeries. With enhanced surgical precision, visualization, and maneuverability, these systems can enable better outcomes in complex cases. The increased uptake across new surgical applications represents a significant opportunity for market growth.
Simulator training for surgeons: Robotic surgery requires specialized skillsets, and extensive training is essential for safe and effective procedures. This presents an opportunity for companies to develop advanced simulation technologies and training programs to assist surgeons in developing robotic surgery skills without risk to patients. Companies like Mimic and 3D Systems provide virtual reality simulators for Da Vinci training. The launch of advanced training tools can help drive wider adoption of robotic surgery.

Da Vinci Systems Market Trends:

Integration with AI and data analytics: Major companies are integrating AI, machine learning, and data analytics capabilities into their robotic surgery platforms to assist in surgical planning, intraoperative decision-making, and training. For instance, intuitive surgical's Da Vinci Xi has integrated connectivity features that allow procedural data collection, training program assessment and performance evaluation. The application of AI and data science in robotic surgery can potentially improve surgical precision and patient outcomes. For instance, an article published on July 6, 2023, on MDPI described that researchers from the Department of Electrical and Computer Engineering, Wayne State University, USA, have introduced a ChatGPT-enabled daVinci surgical robot system that has the potential to enhance the usability of the surgical platform by providing a more user-friendly interface. The system has the capability to understand spoken instructions from the operator and, using the ChatGPT-powered interface, can translate the spoken sentences and context into specific commands to modify the robot's actions or activate particular functions.
Development of single port surgical robots: Leading companies are increasingly focusing on developing robotic systems optimized for single-port surgeries, which require only one small incision. Intuitive Surgical's Da Vinci SP is the first U.S. FDA approved single-port robotic surgical system featuring wristed instruments, 3D visualization, and enhanced flexibility. Other companies, like Titan Medical are also launching robotic platforms purpose-built for single-port procedures. The trend toward single-port robots is expected to continue due to the associated benefits of improved cosmetic results, shorter hospital stays, and faster recovery.
Robotic tele-surgery and portability: Tele-operated surgical robotics is an emerging trend that allows surgeons to remotely operate robotic systems and conduct surgeries across long distances through console connectivity. Companies are also developing lightweight and flexible surgical robots that can be easily moved within the OR which enhances workflow and accessibility. Versius by CMR Surgical is an early example of a portable and modular robotic surgery system. Such innovations in telesurgery and portability will likely gain traction going forward.
Robotic surgery in the outpatient setting: There is an increase in ambulatory surgery centers (ASCs) adopting robotic platforms like the Da Vinci Xi and Si systems to perform outpatient procedures in a minimally invasive manner with faster discharge. As robotic surgery continues to grow, its transition to the outpatient setting would represent improved access and cost benefits compared to the hospital setting. Major companies are increasingly targeting ASCs to drive product adoption.